This is a Validated Antibody Database (VAD) review about rat Serpine1, based on 13 published articles (read how Labome selects the articles), using Serpine1 antibody in all methods. It is aimed to help Labome visitors find the most suited Serpine1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Serpine1 synonym: PAI1A; Pai1; Pai1aa; Planh; RATPAI1A; plasminogen activator inhibitor 1; PAI; PAI-1; endothelial plasminogen activator inhibitor; serine (or cysteine) peptidase inhibitor, clade E, member 1; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; serine (or cysteine) proteinase inhibitor, clade E, member 1; serine (or cysteine) proteinase inhibitor, member 1; serpin E1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
Abcam
rabbit polyclonal |
| Abcam Serpine1 antibody (Abcam, ab66705) was used in western blot on pig samples (fig 5). J Am Heart Assoc (2016) ncbi |
rabbit polyclonal |
| Abcam Serpine1 antibody (Abcam, ab66705) was used in western blot on human samples (fig 1). Sci Rep (2015) ncbi |
rabbit polyclonal |
| Abcam Serpine1 antibody (Abcam, ab66705) was used in immunohistochemistry on human samples at 1:1000. FEBS Lett (2015) ncbi |
rabbit polyclonal |
| Abcam Serpine1 antibody (Abcam, ab66705) was used in western blot on human samples at 1:1000. J Mol Endocrinol (2014) ncbi |
BD Biosciences
mouse monoclonal (41/PAI-1) |
| BD Biosciences Serpine1 antibody (BD Biosciences, 612024) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi |
mouse monoclonal (41/PAI-1) |
| In order to characterize the molecular identity of uterine carcinosarcomas., BD Biosciences Serpine1 antibody (BD Biosciences, 612024) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi |
mouse monoclonal (41/PAI-1) |
| In order to describe the features of 228 primary cervical cancers, BD Biosciences Serpine1 antibody (BD Biosciences, 612024) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi |
mouse monoclonal (41/PAI-1) |
| In order to propose that DLX1 modulates FOXM1 signaling to promote cancer aggressiveness via TGF-beta/SMAD4 signaling in high-grade serous ovarian cancer cells, BD Biosciences Serpine1 antibody (BD Transduction Laboratories, 612024) was used in western blot on human samples (fig 7e). Oncogene (2017) ncbi |
mouse monoclonal (41/PAI-1) |
| In order to study how CUB domain-containing protein1 contributes to metastasis and drug resistance, BD Biosciences Serpine1 antibody (BD Transduction Laboratories, 612024) was used in western blot on human samples (fig 6b). Breast Cancer Res (2016) ncbi |
mouse monoclonal (41/PAI-1) |
| In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, BD Biosciences Serpine1 antibody (BD sciences, P612024) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1). BMC Cancer (2016) ncbi |
mouse monoclonal (41/PAI-1) |
| In order to show that tamoxifen prevents myofibroblast differentiation, BD Biosciences Serpine1 antibody (BD Biosciences, 612025) was used in western blot on human samples at 1:5000. J Cell Physiol (2015) ncbi |
mouse monoclonal (41/PAI-1) |
| BD Biosciences Serpine1 antibody (BD Transduction, 612025) was used in western blot on human samples (fig 11). Nucleic Acids Res (2015) ncbi |
EMD Millipore
mouse monoclonal |
| In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, EMD Millipore Serpine1 antibody (Calbiochem, IM29L-100UG) was used in other on human samples (fig s1). Cell Chem Biol (2017) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments